Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

YY1 Upregulates Checkpoint Receptors and Downregulates Type I Cytokines in Exhausted, Chronically Stimulated Human T Cells.

Balkhi MY, Wittmann G, Xiong F, Junghans RP.

iScience. 2018 Apr 27;2:105-122. doi: 10.1016/j.isci.2018.03.009. Epub 2018 Apr 11.

2.

IKKα deficiency disrupts the development of marginal zone and follicular B cells.

Balkhi MY, Willette-Brown J, Wittmann G, Hu Y.

Genes Immun. 2019 Mar;20(3):224-233. doi: 10.1038/s41435-018-0025-0. Epub 2018 May 8.

PMID:
29740197
3.

Third-Generation Human Epidermal Growth Factor Receptor 2 Chimeric Antigen Receptor Expression on Human T Cells Improves with Two-Signal Activation.

Dalal AR, Homsy S, Balkhi MY.

Hum Gene Ther. 2018 Aug;29(8):845-852. doi: 10.1089/hum.2017.244. Epub 2018 Mar 20.

PMID:
29373929
4.

A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

Yu PY, Balkhi MY, Ladner KJ, Alder H, Yu L, Mo X, Kraybill WG, Guttridge DC, Iwenofu OH.

Lab Invest. 2016 Apr;96(4):481-91. doi: 10.1038/labinvest.2015.168. Epub 2016 Feb 15.

5.

Endotoxin-induced inflammation down-regulates L-type amino acid transporter 1 (LAT1) expression at the blood-brain barrier of male rats and mice.

Wittmann G, Mohácsik P, Balkhi MY, Gereben B, Lechan RM.

Fluids Barriers CNS. 2015 Sep 4;12:21. doi: 10.1186/s12987-015-0016-8.

6.

T cell exhaustion and Interleukin 2 downregulation.

Balkhi MY, Ma Q, Ahmad S, Junghans RP.

Cytokine. 2015 Feb;71(2):339-47. doi: 10.1016/j.cyto.2014.11.024. Epub 2014 Dec 13. Review.

PMID:
25516298
7.

miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.

Balkhi MY, Iwenofu OH, Bakkar N, Ladner KJ, Chandler DS, Houghton PJ, London CA, Kraybill W, Perrotti D, Croce CM, Keller C, Guttridge DC.

Sci Signal. 2013 Jul 30;6(286):ra63. doi: 10.1126/scisignal.2004177. Erratum in: Sci Signal. 2013 Sep 10;6(292):er6. Balkhi, Mumtaz Y [corrected to Balkhi, M Y].

8.

IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis.

Balkhi MY, Willette-Brown J, Zhu F, Chen Z, Liu S, Guttridge DC, Karin M, Hu Y.

Blood. 2012 Jun 7;119(23):5467-77. doi: 10.1182/blood-2012-01-401547. Epub 2012 Apr 27.

9.

IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway.

Balkhi MY, Fitzgerald KA, Pitha PM.

Cell Signal. 2010 Jan;22(1):117-27. doi: 10.1016/j.cellsig.2009.09.021. Epub 2009 Sep 25.

PMID:
19786094
10.

Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination.

Balkhi MY, Fitzgerald KA, Pitha PM.

Mol Cell Biol. 2008 Dec;28(24):7296-308. doi: 10.1128/MCB.00662-08. Epub 2008 Sep 29.

11.

AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.

Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G.

Exp Hematol. 2008 Nov;36(11):1449-60. doi: 10.1016/j.exphem.2008.05.008. Epub 2008 Aug 8.

PMID:
18687517
12.

Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response.

Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA, Pitha PM.

J Biol Chem. 2008 May 23;283(21):14295-308. doi: 10.1074/jbc.M800501200. Epub 2008 Mar 10.

13.

Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9.

Geletu M, Balkhi MY, Peer Zada AA, Christopeit M, Pulikkan JA, Trivedi AK, Tenen DG, Behre G.

Blood. 2007 Nov 1;110(9):3301-9. Epub 2007 Aug 1.

PMID:
17671234
14.

Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link.

Zada AA, Pulikkan JA, Bararia D, Geletu M, Trivedi AK, Balkhi MY, Hiddemann WD, Tenen DG, Behre HM, Behre G.

Leukemia. 2006 Dec;20(12):2137-46. Epub 2006 Nov 2.

PMID:
17082780
15.

Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.

Balkhi MY, Trivedi AK, Geletu M, Christopeit M, Bohlander SK, Behre HM, Behre G.

Oncogene. 2006 Nov 9;25(53):7041-58. Epub 2006 May 29.

PMID:
16732326
16.

Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells.

Latchumanan VK, Balkhi MY, Sinha A, Singh B, Sharma P, Natarajan K.

Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):377-83. Epub 2005 Oct 24.

PMID:
16246624
18.

Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets.

Balkhi MY, Latchumanan VK, Singh B, Sharma P, Natarajan K.

J Leukoc Biol. 2004 May;75(5):874-83. Epub 2004 Feb 13.

PMID:
14966193

Supplemental Content

Loading ...
Support Center